PNC Financial Services Group: Charles River Laboratories CRL Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 4.38 M | Compra |
14,848
+101
| +0.7% | +USD 26.6 k | ﹤0.01% | 835 |
|
|
2026
Q2 | USD 3.34 M | Compra |
14,747
+260
| +2% | +USD 46.3 k | ﹤0.01% | 874 |
|
|
2026
Q1 | USD 2.5 M | Venta |
14,487
-1,571
| -10% | -USD 291 k | ﹤0.01% | 925 |
|
|
2025
Q4 | USD 3.2 M | Compra |
16,058
+301
| +2% | +USD 54.6 k | ﹤0.01% | 823 |
|
|
2025
Q3 | USD 2.47 M | Venta |
15,757
-1,611
| -9% | -USD 256 k | ﹤0.01% | 883 |
|
|
2025
Q2 | USD 2.64 M | Compra |
17,368
+1,442
| +9% | +USD 192 k | ﹤0.01% | 851 |
|
|
2025
Q1 | USD 2.4 M | Compra |
15,926
+1,648
| +12% | +USD 276 k | ﹤0.01% | 862 |
|
|
2024
Q4 | USD 2.64 M | Compra |
14,278
+2,916
| +26% | +USD 562 k | ﹤0.01% | 840 |
|
|
2024
Q3 | USD 2.24 M | Venta |
11,362
-274
| -2% | -USD 56.9 k | ﹤0.01% | 883 |
|
|
2024
Q2 | USD 2.4 M | Venta |
11,636
-106
| -0.9% | -USD 24 k | ﹤0.01% | 846 |
|
|
2024
Q1 | USD 3.18 M | Compra |
11,742
+252
| +2% | +USD 60.2 k | ﹤0.01% | 768 |
|
|
2023
Q4 | USD 2.72 M | Compra |
11,490
+606
| +6% | +USD 119 k | ﹤0.01% | 789 |
|
|
2023
Q3 | USD 2.13 M | Venta |
10,884
-7
| -0.1% | -USD 1.44 k | ﹤0.01% | 837 |
|
|
2023
Q2 | USD 2.29 M | Venta |
10,891
-635
| -6% | -USD 126 k | ﹤0.01% | 843 |
|
|
2023
Q1 | USD 2.33 M | Venta |
11,526
-210
| -2% | -USD 47.6 k | ﹤0.01% | 830 |
|
|
2022
Q4 | USD 2.56 M | Compra |
11,736
+250
| +2% | +USD 54.6 k | ﹤0.01% | 803 |
|
|
2022
Q3 | USD 2.26 M | Compra |
11,486
+113
| +1% | +USD 24.4 k | ﹤0.01% | 828 |
|
|
2022
Q2 | USD 2.43 M | Compra |
11,373
+1,176
| +12% | +USD 287 k | ﹤0.01% | 823 |
|
|
2022
Q1 | USD 2.9 M | Compra |
10,197
+122
| +1% | +USD 37.6 k | ﹤0.01% | 824 |
|
|
2021
Q4 | USD 3.8 M | Compra |
10,075
+5,914
| +142% | +USD 2.3 M | ﹤0.01% | 760 |
|
|
2021
Q3 | USD 1.72 M | Compra |
4,161
+1
| +0% | +USD 415 | ﹤0.01% | 969 |
|
|
2021
Q2 | USD 1.54 M | Venta |
4,160
-1,568
| -27% | -USD 524 k | ﹤0.01% | 1025 |
|
|
2021
Q1 | USD 1.66 M | Venta |
5,728
-1,178
| -17% | -USD 327 k | ﹤0.01% | 958 |
|
|
2020
Q4 | USD 1.72 M | Compra |
6,906
+235
| +4% | +USD 56 k | ﹤0.01% | 892 |
|
|
2020
Q3 | USD 1.51 M | Venta |
6,671
-1,838
| -22% | -USD 381 k | ﹤0.01% | 875 |
|
|
2020
Q2 | USD 1.48 M | Compra |
8,509
+262
| +3% | +USD 41.8 k | ﹤0.01% | 886 |
|
|
2020
Q1 | USD 1.04 M | Compra |
8,247
+1,801
| +28% | +USD 270 k | ﹤0.01% | 953 |
|
|
2019
Q4 | USD 985 k | Venta |
6,446
-7,259
| -53% | -USD 1.01 M | ﹤0.01% | 1100 |
|
|
2019
Q3 | USD 1.81 M | Venta |
13,705
-7,686
| -36% | -USD 1.03 M | ﹤0.01% | 1024 |
|
|
2019
Q2 | USD 3.04 M | Venta |
21,391
-2,044
| -9% | -USD 277 k | ﹤0.01% | 863 |
|
|
2019
Q1 | USD 3.4 M | Venta |
23,435
-925
| -4% | -USD 122 k | ﹤0.01% | 851 |
|
|
2018
Q4 | USD 2.76 M | Venta |
24,360
-437
| -2% | -USD 54.7 k | ﹤0.01% | 887 |
|
|
2018
Q3 | USD 3.34 M | Compra |
24,797
+2,112
| +9% | +USD 261 k | ﹤0.01% | 889 |
|
|
2018
Q2 | USD 2.55 M | Venta |
22,685
-2,109
| -9% | -USD 228 k | ﹤0.01% | 956 |
|
|
2018
Q1 | USD 2.65 M | Compra |
24,794
+683
| +3% | +USD 73.6 k | ﹤0.01% | 935 |
|
|
2017
Q4 | USD 2.64 M | Compra |
24,111
+1,662
| +7% | +USD 181 k | ﹤0.01% | 946 |
|
|
2017
Q3 | USD 2.43 M | Venta |
22,449
-525
| -2% | -USD 53.9 k | ﹤0.01% | 955 |
|
|
2017
Q2 | USD 2.32 M | Compra |
22,974
+242
| +1% | +USD 22.3 k | ﹤0.01% | 949 |
|
|
2017
Q1 | USD 2.04 M | Venta |
22,732
-61
| -0.3% | -USD 5.18 k | ﹤0.01% | 994 |
|
|
2016
Q4 | USD 1.74 M | Compra |
22,793
+17,179
| +306% | +USD 1.3 M | ﹤0.01% | 1055 |
|
|
2016
Q3 | USD 467 k | Compra |
5,614
+1,827
| +48% | +USD 153 k | ﹤0.01% | 1591 |
|
|
2016
Q2 | USD 312 k | Compra |
3,787
+543
| +17% | +USD 44.7 k | ﹤0.01% | 1819 |
|
|
2016
Q1 | USD 246 k | Compra |
3,244
+2,413
| +290% | +USD 179 k | ﹤0.01% | 1966 |
|
|
2015
Q4 | USD 67 k | Compra |
831
+596
| +254% | +USD 43 k | ﹤0.01% | 2682 |
|
|
2015
Q3 | USD 15 k | Compra |
235
+15
| +7% | +USD 1.08 k | ﹤0.01% | 3498 |
|
|
2015
Q2 | USD 15 k | Venta |
220
-84
| -28% | -USD 6.22 k | ﹤0.01% | 3618 |
|
|
2015
Q1 | USD 24 k | Compra |
304
+207
| +213% | +USD 15.3 k | ﹤0.01% | 3417 |
|
|
2014
Q4 | USD 6 k | Compra |
97
+1
| +1% | +USD 63 | ﹤0.01% | 3489 |
|
|
2014
Q3 | USD 6 k | Venta |
96
-7
| -7% | -USD 401 | ﹤0.01% | 3401 |
|
|
2014
Q2 | USD 6 k | Venta |
103
-436
| -81% | -USD 23.9 k | ﹤0.01% | 3256 |
|
|
2014
Q1 | USD 32 k | Compra |
539
+503
| +1,397% | +USD 29.3 k | ﹤0.01% | 2673 |
|
|
2013
Q4 | USD 2 k | Venta |
36
-699
| -95% | -USD 35.1 k | ﹤0.01% | 3240 |
|
|
2013
Q3 | USD 34 k | Compra |
735
+66
| +10% | +USD 3.03 k | ﹤0.01% | 2633 |
|
|
2013
Q2 | USD 27 k | Compra |
+669
| Nuevas | +USD 28.7 k | ﹤0.01% | 2632 |
|
Otros fondos que tienen CRL en su portafolio
Posición de PNC Financial Services Group en CRL: resumen de T3 2026
PNC Financial Services Group aumentó su participación en Charles River Laboratories (CRL) en 0.68% durante T3 2026, al comprar aproximadamente USD 26.6 k y elevar la posición a 14,848 acciones con un valor de USD 4.38 M. La posición representa ﹤0.01% del portafolio y ocupa el puesto #835.
PNC Financial Services Group reportó por primera vez una posición en CRL en T2 2013 y desde entonces la ha mantenido en 54 trimestres. Al cierre de T3 2026, 646 fondos que sigue Wall St. Rank mantienen una posición en CRL.
- Al cierre de T3 2026, PNC Financial Services Group tenía 14,848 acciones de Charles River Laboratories con un valor de USD 4.38 M.
- PNC Financial Services Group compró 101 acciones de Charles River Laboratories en T3 2026, por un monto estimado de USD 26.6 k.
- Charles River Laboratories representó el ﹤0.01% del portafolio de PNC Financial Services Group en T3 2026 y fue su posición número 835.
- PNC Financial Services Group reportó por primera vez una posición en Charles River Laboratories en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- Al cierre de T3 2026, 646 fondos que sigue Wall St. Rank tenían Charles River Laboratories en su portafolio.
Según el informe 13F de PNC Financial Services Group correspondiente a T3 2026, presentado el 6 nov 2026.